Showing 15 posts of 467 posts found.


Britain call on companies to bid for 24 hour Brexit medicines shipping service contract

August 15, 2019
Business Services, Sales and Marketing UK, brexit, britain, medicines, pharma

The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers …


EU unprepared for no-deal Brexit, health experts warn

August 12, 2019
Sales and Marketing EU, Euroepan Union, UK, brexit, pharma

European health experts have warned that a no-deal Brexit could worsen medicines shortages in the European Union. Speaking to Reuters, …


Keytruda/chemo combo recommended for first-line lung cancer via Cancer Drugs Fund

August 8, 2019
Sales and Marketing CDF, Cancer, MSD, NHS, NICE, UK, keytruda, lung cancer, pharma

MSD’s Keytruda (pembrolizumab) has secured recommendation from NICE for inclusion on the Cancer Drugs Fund (CDF) in combination with chemotherapy …

NICE recommends Pierre Fabre’s Nerlynx in adjuvant HER2+ breast cancer

August 7, 2019
Research and Development, Sales and Marketing Cancer, NCIE, NHS, Nerlynx, Pierre Fabre, UK, breast cancer

Pierre Fabre’s Nerlynx (neratinib) has been recommended by NICE as a new option for NHS patients with early hormone-receptor-positive, human …


Medicinal cannabis company Spectrum makes first shipment into UK

August 7, 2019
Research and Development Spectrum, UK, cannabis, medicinalcannabis, pharma

Medicinal cannabis company Spectrum Europe has made its first shipment of cannabis into the UK, making it one of the …


NICE reject Clovis Oncology’s ovarian cancer drug Rubraca

August 6, 2019
Manufacturing and Production NHS, NICE, Rubraca, UK, guidance, pharma

Britain’s cost-effectiveness body NICE has chosen not to recommend Clovis Oncology’s cancer drug Rubraca (rucaparib). On 6 August, NICE issued …


Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages

August 2, 2019
Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma

Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …

Bayer’s Xarelto combo greenlighted by NICE for reducing CV events in artery disease

August 1, 2019
Sales and Marketing NHS, NICE, UK, Xarelto, cardiovascular disease, pharma

NICE has awarded final appraisal recommendation to Bayer’s Xarelto (rivaroxaban) at a dosage of 2.5mg twice daily in combination with …


The patient is always right: Extracting the full value of PROMs

July 29, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …


Top Ten most popular articles on this week

July 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biohaven, FDA, Lyrica, NICE, Pfizer, UK, US, pharma, top ten

At the end of a week that could certainly be called “eventful” here in the UK – one that saw …


London’s water contains high levels of antibiotic-resistant genes, UCL research reveals

July 26, 2019
Medical Communications, Research and Development London, UCL, UK, antibiotic resistance, pharma

Research from University College London has warned that freshwater sources in the English capital of London contain high levels of …

AstraZeneca’s Lynparza approved via Cancer Drugs Fund for BRCA+ gynaecological cancers

July 26, 2019
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Cancer Drugs Fund, NHS, NICE, UK, lynparza, pharma

NICE has published final guidance which approves AstraZeneca’s Lynparza (olaparib) for use on the NHS as a maintenance therapy for …


NICE to review its decision making processes

July 22, 2019
Sales and Marketing Cost, NHS, NICE, UK, britain, pharma

Britain’s cost-effectiveness body NICE has said it will review the methods it uses to develop guidance on drugs, medical devices, …


Government spend £9.2 billion on private healthcare providers for NHS in 2018-19

July 22, 2019
Sales and Marketing DHSC, NHS, UK, health, healthcare, politics, private providers

The Department of Health and Social Care paid £9.2 billion to private providers in the year prior to 31 March …


Number of UK animal testing procedures falls to lowest level since 2007

July 19, 2019
Medical Communications, Research and Development Animal testing, UK, drug development, pharma, rresearch

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …

Latest content